Acer Therapeutics
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1180 Celebration Blvd Ste 103, Celebrati...Phone Number
(844) 902-6100Website
www.acertx.comRevenue
<$5 MillionStock Symbol
ACERIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Acer Therapeutics
Founded in 2013, Acer Therapeutics Inc. develops re-purposed and reformulated medicines to treat ultra-orphan diseases. It is located in Cambridge, Massachusetts.Explore more
Acer Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acer Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Acer Therapeutics is spiking on competitors!
Acer Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Acer Therapeutics has new funding data
Product Launch: Get notified when Acer Therapeutics launches new products
Click to see if Acer Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Acer Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Acer Therapeutics
Check if Acer Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Acer Therapeutics
Compare insights from companies similar to Acer Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Acer Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Acer Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Acer Therapeutics.
Acer Therapeutics financials insights
Gather financial insights about Acer Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$4.1M
2016
Series B
$8.1M
2017
Debt
$3.1M
2020
Debt
$350K
Share Placement
$15M
Acer Therapeutics Tech Stack
A closer look at the technologies used by Acer Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Mergers & Acquisitions (M&A)
Lateral Move
Executive Move
Promotion
Executive Move
Acer Therapeutics News & Media
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Acer Therapeutics Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - September 6, 2023) - Rigrodsky Law, P.A. is investigating Acer Therapeutics Inc. ("Acer") (NASDAQ: ACER) regarding possible breaches of fiduciary duties and other violations of law related to Acer's agreement to be acquired by Zevra Therapeutics, Inc. ("Zevra"). Under the terms of the agreement, Acer shareholders will receive 0.121 shares of Zevra's common stock for each share of Acer's common stock owned.To learn more about this investigation and your...Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra
MILWAUKEE, Aug. 31, 2023 /PRNewswire/ -- Ademi LLP is investigating Acer (Nasdaq: ACER) for possible breaches of fiduciary duty and other violations of law in its transaction with Zevra. Click here to learn how to join the action https://www.ademilaw.com/case/acer-therapeutics-inc or call...ACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Acer Therapeutics Inc. (NASDAQ: ACER) to Zevra Therapeutics, Inc. for 0.121 of a share of Zevra’s common stock for each share of Acer’s common stock is fair to Acer shareholders. Additionally, Acer stockholders would receive non-transferable Contingent Value Rights entitling them to receive up to $34 million in cash upon the achievement of certain commercial milestones for OLPRUVA, andAcer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
Promissory note extends cash runway into early Q3 2023 OLPRUVA™ expected to be available by prescription in the U.S. beginning July 5 th NEWTON, Mass., June 26, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nas...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Acer Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2013, Acer Therapeutics Inc. develops re-purposed and reformulated medicines to treat ultra-orphan diseases. It is located in Cambridge, Massachusetts.... Read More
